Cerivastatin: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>David E. Volk
mNo edit summary
imported>David E. Volk
Line 32: Line 32:


== External links ==
== External links ==
* {{DailyMed}}
* {{CZMed}}
* {{MedMaster}}
* {{DrugBank}}

Revision as of 18:04, 25 June 2008

This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.
(CC) Image: David E. Volk
Cerivastatin, a type II statin.

Cerivastatin, sold as Lipobay, Rivastatin and Baycol, now withdrawn from the U.S. and Canadian markets, is a type II statin formerly used to treat high cholesterol levels (hypercholesterolemia), prevent heart attacks and strokes, and to diminish the formation of arterial plaque. Baycol was voluntarily removed from the U.S. market in August of 2001 by Bayer Pharmaceutical Division due to reports of fatal rhabdomyolysis. It is a HMG-CoA reductase inhibitor which diminishes the conversion of HMG-CoA to mevalonate, a key chemical precursor of cholesterol. It is structurally related to the other type II statins, fluvastatin, atorvastatin (Lipitor) and rosuvastatin (Crestor).


brand names

  • Baycol (withdrawn from US and Canadian markets)
  • Lipobay
  • Rivastatin

Drug interactions

External links